Ovid Therapeutics, Inc. (OVID)
1.595
-0.06
(-3.33%)
USD |
NASDAQ |
Jan 15, 16:00
1.595
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics SG&A Expense (TTM): 22.56M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| AnaptysBio, Inc. | 45.14M |
| Ionis Pharmaceuticals, Inc. | 351.68M |
| MannKind Corp. | 195.42M |
| Cassava Sciences, Inc. | 68.06M |
| Cogent Biosciences, Inc. | 51.34M |